Fundraising by biopharmaceutical companies surged in 2024 to $86.67bn, up 16.2% from $74.59bn in 2023, according to data collected by Biomedtracker. The good fortune was shared across both public and
“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning
Chronically Infected HBV Patients: The Final Frontier Hepatitis B virus (HBV) is a double-stranded DNA virus that results in human infection with acute and chronic disease phases in the liver. The acu
There was a slew of COVID-19 vaccine approvals in India in late December. In China, the focus was on investigational therapeutics. India Nuvaxovid Gets Green Light As had been expected, the Drugs Cont